| Literature DB >> 30589906 |
Michael Marks1,2, Daniel Engelman3,4, Lucia Romani5, Daniel Mason3,4, Oliver Sokana6, Mike Kama7, Margot Whitfeld8, Andrew C Steer3,4, John Kaldor5.
Abstract
INTRODUCTION: In most settings, the diagnosis of scabies is reliant on time-consuming and potentially intrusive clinical examination of all accesible regions of skin. With the recent recognition of scabies as a neglected tropical disease by the World Health Organization there is a need for standardised approaches to disease mapping to define populations likely to benefit from intervention, and to measure the impact of interventions. Development and validation of simplified approaches to diagnose scabies would facilitate these efforts.Entities:
Mesh:
Year: 2018 PMID: 30589906 PMCID: PMC6307692 DOI: 10.1371/journal.pntd.0006996
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Proportion of scabies cases identified by body region.
| Body Site | n | Percentage of scabies cases with site involved | Exposed or Unexposed |
|---|---|---|---|
| Any Body Region | 1373 | 100% | N/A |
| Face | 46 | 3.4% | Exposed |
| Upper Arm | 238 | 17.3% | Exposed |
| Lower Arm | 400 | 29.1% | Exposed |
| Hand | 703 | 51.2% | Exposed |
| Torso | 194 | 14.1% | Unexposed |
| Buttock/Groin | 94 | 6.8% | Unexposed |
| Upper Leg | 310 | 22.6% | Unexposed |
| Lower Leg | 663 | 48.3% | Exposed |
| Feet | 682 | 49.7% | Exposed |
Sensitivity of limited examination across population subgroups.
| Lower Arms, | Whole Arms, | All exposed | ||
|---|---|---|---|---|
| Male | 87.8 (85.0–90.1)* | 92.9 (90.7–94.7) | 93.6 (91.5–95.3) | |
| Female: | 86.5 (83.4–88.9)* | 92.0 (89.7–93.9) | 94.4 (92.2–95.6) | |
| 0-4yrs: | 91.0 (86.7–94.1) | 92.2 (88.0–95.0) | 93.3 (89.4–95.9) | |
| 5-9yrs: | 91.7 (88.3–94.2) | 94.5 (91.5–96.5) | 95.3 (92.4–97.2 | |
| 10-14yrs: | 94.5 (91.1–96.7) | 95.9 (92.7–97.8) | 96.6 (93.4–98.2) | |
| 15-24yrs: | 89.8 (81.0–94.9) | 96.6 (89.7–99.1) | 96.6 (89.7–99.1) | |
| 25/49yrs: | 80.6 (74.5–85.5)* | 90.3 (85.3–93.7) | 91.7 (86.9–94.8) | |
| 50+yrs: | 67.6 (59.2–75.0)* | 88.0 (81.3–92.7) | 88.7 (82.1–93.2) | |
| Absent | 84.5 (81.6–86.9)* | 93.0 (90.8–94.6) | 94.1 (92.2–95.7) | |
| Present | 91.8 (89.3–93.8) | 93.4 (91.1–95.2) | 93.9 (91.6–95.6) | |
| Mild | 84.9 (82.0–87.5)* | 91.4 (89.0–93.3) | 92.7 (90.4–94.5) | |
| Moderate | 88.1 (84.9–90.7)* | 93.8 (91.2–95.6) | 94.3 (91.9–96.1) | |
| Severe | 97.8 (93.9–99.3) | 98.3 (94.7–99.6) | 98.3 (94.7–99.6) |
*p<0.01 for comparison to sensitivity when including upper arm
Demographic characteristics of participants in three surveys of scabies prevalence.
| n | % | ||
|---|---|---|---|
| Male | 2557 | 47.7% | |
| Female: | 2801 | 52.3% | |
| 0-4yrs: | 763 | 14.2% | |
| 5-9yrs: | 1026 | 19.1% | |
| 10-14yrs: | 904 | 16.9% | |
| 15-24yrs: | 491 | 9.2% | |
| 25/49yrs: | 1412 | 26.4% | |
| 50+yrs: | 692 | 12.9% | |
| Absent | 3985 | 74.4% | |
| Present | 1373 | 25.6% | |
| N/A | 3985 | 74.4% | |
| Mild | 684 | 12.8%* | |
| Moderate | 513 | 9.6%* | |
| Severe | 176 | 3.2%* | |
| Absent | 3933 | 73.4% | |
| Present | 1425 | 26.6% |
*% of all individuals
Prevalence estimates by simplified examination.
| n | Reference Standard Examination | Lower Arms, | Whole Arms, | Whole Arms, | |
|---|---|---|---|---|---|
| 1908 | 19.2 | 17.2 | 18.0 | 18.1 | |
| 1399 | 18.7 | 16.4 | 17.4 | 17.4 | |
| 2051 | 36.4 | 31.5 | 33.7 | 34.2 |